Jen Shah is officially out of prison. The Real Housewives of Salt Lake City alum, 52, was released on Wednesday, December 10, ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ('Moleculin” or the 'Company”), a late-stage pharmaceutical company with a broad ...

Minimal residual disease is “a credible intermediate endpoint” for some patients with newly diagnosed acute myeloid leukemia, researchers report.

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that ...

Guidelines recommend older adults with newly diagnosed AML should be offered antileukemic therapy over best supportive care.

THE HAGUE, NL / ACCESS Newswire / December 10, 2025 / The Global Anti-Scam Alliance (GASA) is pleased to announce that Nasdaq Verafin has joined GASA as a Foundation Member, strengthening the global ...

This study retrospectively analyzed ten pediatric patients with HOX-driven AML who received revumenib maintenance after HSCT at a single-center. The median age was 10 years (range: 1-18). 80% (8/10) ...

RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) based on preliminary clinical ...

It’s official: “Six Seven” Just earned the title of Dictionary.com’s 2025 Word of the Year. But even as the word is officially added to the cultural lexicon, it has already been quietly removed ...